{"id":"NCT00103857","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)","officialTitle":"A Multicenter, Randomized, Double-Blind Factorial Study of the Co-Administration of MK0431 and Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03-17","primaryCompletion":"2006-07-25","completion":"2008-02-21","firstPosted":"2005-02-16","resultsPosted":"2009-05-19","lastUpdate":"2017-05-05"},"enrollment":1208,"design":{"allocation":"RANDOMIZED","model":"FACTORIAL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Comparator: MK0431 50 mg b.i.d. (b.i.d. = twice daily)","otherNames":["MK0431"]},{"type":"DRUG","name":"Comparator: MK0431 100 mg q.d. (q.d. = once daily)","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo (Phase A)/Metformin (Phase B)","otherNames":[]},{"type":"DRUG","name":"Comparator: Metformin 500 mg b.i.d.","otherNames":[]},{"type":"DRUG","name":"Comparator: Open-Label MK0431/Metformin 50/1000 mg b.i.d.","otherNames":[]},{"type":"DRUG","name":"Comparator: Metformin 1000 mg b.i.d.","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"ACTIVE_COMPARATOR"},{"label":"4","type":"EXPERIMENTAL"},{"label":"5","type":"EXPERIMENTAL"},{"label":"6","type":"PLACEBO_COMPARATOR"},{"label":"7","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Hemoglobin A1C) at Week 24","timeFrame":"Week 24","effectByArm":[{"arm":"Sitagliptin 100 mg q.d.","deltaMin":-0.66,"sd":null},{"arm":"Metformin 500 mg b.i.d.","deltaMin":-0.82,"sd":null},{"arm":"Metformin 1000 mg b.i.d.","deltaMin":-1.13,"sd":null},{"arm":"Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d.","deltaMin":-1.4,"sd":null},{"arm":"Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d.","deltaMin":-1.9,"sd":null},{"arm":"Placebo/Metformin 1000 mg b.i.d.","deltaMin":0.17,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17485570","32501595"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15},"commonTop":["Any Infections And Infestations","Any Gastrointestinal Disorders","Any Musculoskeletal And Connective Tissue Disorders","Diarrhoea","Upper Respiratory Tract Infection"]}}